Singulair (montelukast) for asthma

March 1998

    Merck is introducing Singulair (montelukast) for asthma.

    It's a new leukotriene antagonist...in the same class as Accolate (zafirlukast). It's a little different than Zyflo.

   Singulair and Accolate block the ACTION of leukotrienes in the lungs...Zyflo (zileuton) inhibits their PRODUCTION.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote